EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Serum Growth Factors and Risk of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A One-Year Prospective Study

Hong-Yih Tien, Chung-Yu Chen iD, Chong-Jen Yu, Hao-Chien Wang

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hong-Yih Tien und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, National Taiwan University Hospital Yunlin Branch, Douliou City 640204, Yunlin County, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Intercellular Signaling Peptides and Proteins. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University Hospital Yunlin Branch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation associated with enhanced chronic airway inflammation. Growth factors implicated in COPD’s inflammatory processes may serve as biomarkers for disease progression and exacerbation risk. This study evaluated the relationship between serum growth factors and COPD exacerbations over one year. Serum levels of eleven growth factors, including brain-derived neurotrophic factor (BDNF), leukemia inhibitory factor (LIF), fibroblast growth factor-2 (FGF-2), vascular endothelial growth factor (VEGF), nerve growth factor (NGF), epidermal growth factor (EGF), and stem cell factor (SCF), were measured in COPD patients at baseline. Participants were followed prospectively for one year, and associations between these biomarkers and acute exacerbations (AE) and frequent acute exacerbations (Frequent AE) were assessed using statistical analyses and receiver operating characteristic (ROC) curves. Among the study population, 42 patients experienced at least one AE within the follow-up period. Lower serum FGF-2 levels were significantly associated with increased AE risk (adjusted odds ratio significant after covariate adjustment). ROC analysis identified FGF-2 ≤ 9.12 pg/mL as a predictor of AE (AUC = 0.614, sensitivity = 64.3%, specificity = 57.1%, p = 0.032). For Frequent AE, eight patients experienced multiple exacerbations and exhibited significantly lower levels of NGF, EGF, FGF-2, and LIF. After adjustment, NGF remained significantly predictive; NGF ≤ 25.23 pg/mL demonstrated strong discriminatory power for Frequent AE (AUC = 0.797, p < 0.001). However, interpretations are limited by the small Frequent AE subgroup. Serum growth factors, particularly FGF-2 and NGF, are associated with COPD exacerbation risk. Lower serum FGF-2 may indicate a higher likelihood of acute exacerbations, while lower NGF strongly predicts frequent exacerbations. Larger studies and longer follow-ups are needed to confirm these biomarkers’ predictive utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveIntercellular Signaling Peptides and ProteinsHumansMaleFemaleAgedBiomarkersProspective StudiesMiddle AgedDisease ProgressionROC CurveRisk FactorsNerve Growth FactorEpidermal Growth FactorFibroblast Growth Factor 2

Stichwörter der Autor:innen

acute exacerbationbiomarkerschronic obstructive pulmonary diseasefibroblast growth factorgrowth factorsnerve growth factorrisk stratification

Substanzen

BiomarkersIntercellular Signaling Peptides and ProteinsNerve Growth FactorEpidermal Growth FactorFibroblast Growth Factor 2

Autor:innen und Institutionen

  • Department of Emergency Medicine, National Taiwan University Hospital Yunlin Branch, Douliou City 640204, Yunlin County, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Douliou City 640204, Yunlin County, Taiwan.
  • College of Medicine, National Taiwan University, Taipei 100225, Taiwan.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100225, Taiwan.

ORCID-Profile: Chung-Yu Chen

Förderung

  • National Taiwan University Hospital Yunlin Branch

Zitieren

APA

Tien, H. Y., Chen, C. Y., Yu, C. J., & Wang, H. C. (2025). Association Between Serum Growth Factors and Risk of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A One-Year Prospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110584

Vancouver

Tien HY, Chen CY, Yu CJ, Wang HC. Association Between Serum Growth Factors and Risk of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A One-Year Prospective Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110584

BibTeX
@article{Tien2025,
  author = {Tien, Hong-Yih and Chen, Chung-Yu and Yu, Chong-Jen and Wang, Hao-Chien},
  title = {Association Between Serum Growth Factors and Risk of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A One-Year Prospective Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110584}
}
Kostenlos starten →